Quality of life and the experience of living with early-stage Alzheimer’s disease

Manuscript Number: 

22-0696R1

Author(s): 
Pedro Abizanda-Soler, Rafael Arroyo, Mircea Balasa, Miquel Baquero-Toledo, Ángel Berbel, Mercè Boada, Inmaculada Feria-Vilar, Emilio Franco-Macías, Elena García-Arcelay, Guillermo García-Ribas, Almudena Ibañez de la Peña, Alberto Lleó, Jorge Maurino, Gerard Piñol-Ripoll, Daniel Prefasi, Albert Puig-Pijoan, Mario Riverol, Silvia Rodrigo-Herrero, Eloy Rodriguez-Rodriguez, Ángeles Terrancle, Alba Vieira-Campos, Alberto Villarejo-Galende, Félix Viñuela, Antonio del Olmo-Rodríguez

Disclosures

Pedro Abizanda-Soler

  • Nothing to Disclose

Rafael Arroyo

  • Nothing to Disclose

Mircea Balasa

  • Nothing to Disclose

Miquel Baquero-Toledo

  • Nothing to Disclose

Ángel Berbel

  • Consulting Fees:
    Schwabbe. Advisory boards Nutricia. Advisory boards Roche. Consulting fees

Mercè Boada

  • Consulting Fees:
    Consulting fees: Grifols, Araclon Biotech, Roche, Biogen, Lilly, Merck, Zambon. Advisory Boards: Grifols, Roche, Lilly, Araclon Biotech, Merck, Zambon, Biogen, Novo-Nordisk, Bioiberica, Eisai, Servier, Schwabe Pharma
    Lecture Fees:
    Lectures: Roche, Biogen, Grifols, Nutricia, Araclon Biotech, Servier, Novo-Nordisk
    Grants
    • Agency: 
      CIBERNED (Instituto de Salud Carlos III (ISCIII), EU/EFPIA Innovative Medicines Initiative Joint Undertaking, ADAPTED Grant No. 115975, from EXIT project, EU Euronanomed3 Program JCT2017 Grant No. AC17/00100, MOPEAD, Innovative Medicine Initiative, Gran
      Dates: 
      Received by the entity
    • Agency: 
      Funding Sources: Life Molecular Imaging, Bioiberica, Grifols, Araclon Biotech, Roche, Janssen
      Dates: 
      Received by the entity

Antonio del Olmo-Rodríguez

  • Lecture Fees:
    Honorarios Ponencia Reunión Virtual "V Neuroacademy: Enfermedad de Alzheimer" 23 de marzo de 2021: 825,00€.

Inmaculada Feria-Vilar

  • Nothing to Disclose

Emilio Franco-Macías

  • Nothing to Disclose

Elena García-Arcelay

  • Sponsors:
    I am Roche Farma Employee

Guillermo García-Ribas

  • Nothing to Disclose

Almudena Ibañez de la Peña

  • Nothing to Disclose

Alberto Lleó

  • Nothing to Disclose

Jorge Maurino

  • Sponsors:
    I am an employee of Roche Farma Medical Department, Spain.

Gerard Piñol-Ripoll

  • Nothing to Disclose

Daniel Prefasi

  • Nothing to Disclose

Albert Puig-Pijoan

  • Nothing to Disclose

Mario Riverol

  • Nothing to Disclose

Silvia Rodrigo-Herrero

  • Nothing to Disclose

Eloy Rodriguez-Rodriguez

  • Consulting Fees:
    Novonordisk (june 2022) Clinical trial strategy Roche (october 2022) Clinical trail strategy

Ángeles Terrancle

  • Sponsors:
    Operational manager of the study

Alba Vieira-Campos

  • Nothing to Disclose

Alberto Villarejo-Galende

  • Consulting Fees:
    Consulting fees from Roche, AbbVie and Novo-Nordisk
    Lecture Fees:
    Esteve, Kern Pharma, KRKA, Roche,

Félix Viñuela

  • Nothing to Disclose